IGF2 and amyotrophic lateral sclerosis: We anticipate that delivery of IGF-2 or IGF-1 directly to motor neurons, using gene therapy, either through muscle injections and retrograde delivery to motor neuron somas or intraspinal injections, could confer localized neurotrophic support directly to motor neurons and be beneficial to ALS patient.